Stockscreener 앱 받기
1.425
3.06%
-0.045
전일 마감가:
$1.47
열려 있는:
$1.43
하루 거래량:
125.19K
Relative Volume:
0.03
시가총액:
$24.83M
수익:
$174.80K
순이익/손실:
$-8.85M
주가수익비율:
-2.0691
EPS:
-0.6887
순현금흐름:
$-4.37M
1주 성능:
-3.72%
1개월 성능:
+56.58%
6개월 성능:
-20.39%
1년 성능:
-47.42%
1일 변동 폭
$1.40
$1.43
1주일 범위
$1.40
$1.65
52주 변동 폭
$0.702
$4.4899
Nexalin Technology Inc Stock (NXL) Company Profile
명칭
Nexalin Technology Inc
전화
(832) 260-0222
주소
1776 YORKTOWN, HOUSTON
NXL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NXL
Nexalin Technology Inc
|
1.4256 | 26.74M | 174.80K | -8.85M | -4.37M | -0.6887 |
|
ABT
Abbott Laboratories
|
125.47 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
360.57 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.02 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.37 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
Nexalin Technology Inc 주식(NXL)의 최신 뉴스
Statistical indicators supporting Nexalin Technology Inc.’s strengthMarket Performance Report & Daily Stock Momentum Reports - newser.com
How to monitor Nexalin Technology Inc. with trend dashboardsWeekly Risk Summary & AI Powered Market Trend Analysis - newser.com
Can Nexalin Technology Inc. stock outperform in 2025 bull marketJuly 2025 Decliners & Stepwise Swing Trade Plans - newser.com
Detecting support and resistance levels for Nexalin Technology Inc.July 2025 Levels & Stepwise Entry and Exit Trade Signals - newser.com
Is Nexalin Technology Inc. Equity Warrant stock bottoming outWatch List & Safe Capital Investment Plans - newser.com
Should you wait for a breakout in Nexalin Technology Inc.Earnings Growth Report & Expert Verified Movement Alerts - newser.com
How analysts rate Nexalin Technology Inc. stock todayDividend Hike & Growth Oriented Trading Recommendations - newser.com
Will Nexalin Technology Inc. Equity Warrant stock benefit from automation2025 Sector Review & Accurate Entry/Exit Alerts - newser.com
What momentum shifts mean for Nexalin Technology Inc.2025 Support & Resistance & Verified Chart Pattern Trade Signals - newser.com
How to monitor Nexalin Technology Inc. Equity Warrant with trend dashboardsJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
What data driven models say about Nexalin Technology Inc.’s futureTrade Ideas & Daily Profit Maximizing Tips - newser.com
Trend analysis for Nexalin Technology Inc. this weekGlobal Markets & Real-Time Stock Entry Alerts - newser.com
How high can Nexalin Technology Inc. stock goWeekly Trade Review & Capital Efficiency Focused Strategies - newser.com
Price momentum metrics for Nexalin Technology Inc. explainedJuly 2025 EndofMonth & Safe Entry Trade Reports - newser.com
Is Nexalin Technology Inc. forming a bottoming baseJuly 2025 Big Picture & Smart Investment Allocation Tips - newser.com
Historical volatility pattern of Nexalin Technology Inc. Equity Warrant visualizedWeekly Stock Summary & Accurate Buy Signal Alerts - newser.com
MSN Money - MSN
Momentum divergence signals in Nexalin Technology Inc. chartQuarterly Trade Summary & Long-Term Capital Growth Strategies - newser.com
Can Nexalin Technology Inc. stock attract ESG capital inflowsJobs Report & Daily Momentum Trading Reports - newser.com
Is a relief rally coming for Nexalin Technology Inc. Equity Warrant holdersQuarterly Trade Report & Weekly Momentum Picks - newser.com
Analyzing drawdowns of Nexalin Technology Inc. with statistical toolsQuarterly Earnings Summary & Daily Technical Forecast Reports - newser.com
How geopolitical tensions affect Nexalin Technology Inc. stockJuly 2025 Levels & Technical Entry and Exit Tips - newser.com
Is it too late to sell Nexalin Technology Inc.Entry Point & Community Verified Trade Signals - newser.com
How Nexalin Technology Inc. stock compares to industry benchmarksAnalyst Downgrade & High Conviction Buy Zone Alerts - newser.com
Can Nexalin Technology Inc. stock double in next 5 yearsMarket Movement Recap & AI Forecasted Entry and Exit Points - newser.com
Will Nexalin Technology Inc. Equity Warrant stock benefit from AI adoptionDay Trade & AI Enhanced Trading Signals - newser.com
Price action breakdown for Nexalin Technology Inc. Equity Warrant2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - newser.com
What high frequency data says about Nexalin Technology Inc. Equity WarrantMarket Sentiment Report & Community Verified Trade Alerts - newser.com
Is this a good reentry point in Nexalin Technology Inc.Short Setup & Daily Technical Forecast Reports - newser.com
Is Nexalin Technology Inc. stock a buy for dividend growthTrade Volume Report & Daily Market Momentum Tracking - newser.com
Published on: 2025-11-02 23:00:18 - newser.com
Why Nexalin Technology Inc. stock is in analyst buy zoneJuly 2025 Chart Watch & Free Reliable Trade Execution Plans - newser.com
Chart overlay techniques for tracking Nexalin Technology Inc. Equity Warrant2025 Institutional Moves & Growth Focused Investment Plans - newser.com
Analyzing Nexalin Technology Inc. with multi timeframe charts2025 Technical Overview & Community Consensus Picks - newser.com
Can Nexalin Technology Inc. stock reach $100 price target2025 Earnings Surprises & AI Driven Price Predictions - newser.com
Risk vs reward if holding onto Nexalin Technology Inc.July 2025 Institutional & Weekly High Potential Stock Alerts - newser.com
Will Nexalin Technology Inc. stock sustain high P E ratiosJuly 2025 Short Interest & Weekly Breakout Watchlists - newser.com
Nexalin Technology Inc (NXL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Nexalin Technology Inc 주식 (NXL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Shelton Carolyn Hamby | Sr. VP - Quality, Regulatory |
Mar 12 '25 |
Buy |
2.20 |
6,000 |
13,200 |
30,000 |
| Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
3.10 |
1,000 |
3,100 |
155,793 |
| Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
2.98 |
1,000 |
2,980 |
154,793 |
| Owens David | Chief Medical Officer |
Jan 28 '25 |
Buy |
2.70 |
1,500 |
4,050 |
153,793 |
| Owens David | Chief Medical Officer |
Jan 13 '25 |
Buy |
2.50 |
2,000 |
5,000 |
151,293 |
| Owens David | Chief Medical Officer |
Jan 23 '25 |
Buy |
2.70 |
1,000 |
2,700 |
152,293 |
0.35%
0.67%
자본화:
|
볼륨(24시간):